Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of SR750 for trigeminal neuralgia
CTR20242886Phase 2Completed
- Sponsor
- SimuRoad Biotechnology
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in trigeminal neuralgia (TN) and Peripheral neuropathic pain comparing SR750 with Placebo (2 arms). Started Sep 2024; status: completed.
02
Drugs
SR750
03
Conditions
trigeminal neuralgia (TN)Peripheral neuropathic pain
Beyond the preview
Go deeper on CTR20242886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242886.